Is Higher Dose of Inhaled Treprostinil Truly Superior to Lower Dose of Inhaled Treprostinil in Patients With Pulmonary Hypertension Associated With Interstitial Lung Diseases?

被引：0
|
作者：
Genecand, Leon [1 ]
Lador, Frederic [1 ]
Montani, David [2 ]
Perneger, Thomas [3 ,4 ]
机构：
[1] Univ Hosp Geneva, Dept Med, Div Pneumol, Geneva, Switzerland
[2] Univ Paris Saclay, Hop Bicetre, Pulm Hypertens Natl Referral Ctr, AP AP,Dept Resp & Intens Care Med,INSERM,UMR S 999, Gif Sur Yvette, France
[3] Univ Geneva, Dept Hlth & Community Med, Div Clin Epidemiol, Geneva, Switzerland
[4] Univ Hosp Geneva, Geneva, Switzerland
来源：
CHEST | 2024年 / 165卷 / 05期
关键词：
D O I：
10.1016/j.chest.2023.12.032
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：e161 / e161
页数：1
相关论文
共 50 条
  • [11] Inhaled Treprostinil in Pulmonary Hypertension in the Context of Interstitial Lung Disease: A Success, Finally
    Behr, Juergen
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (02) : 144 - 146
  • [12] Efficacy and determinants of response to inhaled treprostinil in pulmonary hypertension - interstitial lung disease
    Balakrishnan, Bathmapriya
    Azar, Jehad
    Farha, Samar
    Goyanes, Alice M.
    Lane, James E.
    Paul, Deborah
    Highland, Kristin B.
    Wang, Yifan
    Wang, Xiaofeng
    Tonelli, Adriano R.
    RESPIRATORY MEDICINE, 2024, 234
  • [13] Inhaled treprostinil sodium for pulmonary hypertension
    Gupta, Vedant
    Krasuski, Richard A.
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (03): : 283 - 291
  • [14] Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension
    Raina, Amresh
    Coons, James C.
    Kanwar, Manreet
    Murali, Srinivas
    Sokos, George
    Benza, Raymond L.
    PULMONARY CIRCULATION, 2013, 3 (01) : 116 - 120
  • [15] Inhaled treprostinil and pulmonary arterial hypertension
    Nadler, Samuel T.
    Edelman, Jeffrey D.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2010, 6 : 1115 - 1124
  • [16] LONG-TERM SAFETY AND TOLERABILITY OF INHALED TREPROSTINIL IN PATIENTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE
    Waxman, Aaron B.
    Elwing, Jean M.
    Melendres-Groves, Lana
    Risbano, Michael G.
    Lenneman, Andrew J.
    Tapson, Victor F.
    Shen, Eric
    Smith, Peter
    Deng, C. Q.
    Nathan, Steven D.
    CHEST, 2022, 162 (04) : 2330A - 2332A
  • [17] Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical Outcomes
    Nathan, Steven D.
    Deng, Chunqin
    King, Christopher S.
    DuBrock, Hilary M.
    Elwing, Jean
    Rajagopal, Sudarshan
    Rischard, Franz
    Sahay, Sandeep
    Broderick, Meredith
    Shen, Eric
    Smith, Peter
    Tapson, Victor F.
    Waxman, Aaron B.
    CHEST, 2023, 163 (02) : 398 - 406
  • [18] Interstitial lung disease with pulmonary hypertension and the potential for inhaled Treprostinil: A single centre perspective
    Ramjug, S.
    Hayton, C.
    Rivera-Ortega, P.
    Leonard, C.
    Morris, H.
    Zakis, K.
    Swale, J.
    Garfoot, T.
    Newman, K.
    Avram, C.
    Blaikley, J.
    Chaudhuri, N.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [19] USE OF INHALED TREPROSTINIL IN PULMONARY HYPERTENSION AND COPD
    Al-Bedour, Arwa
    Guice, Kenneth C.
    Sheikh, Muhammad M.
    CHEST, 2022, 162 (04) : 2411A - 2411A
  • [20] Inhaled Treprostinil for the Treatment of Pulmonary Arterial Hypertension
    Poms, Abby
    Kingman, Martha
    CRITICAL CARE NURSE, 2011, 31 (06) : E1 - E11
12345